Bio-Techne
Yahoo Finance • 15 days ago
Bio-Techne (NASDAQ:TECH) shareholders have earned a 8.3% CAGR over the last five years
Bio-Techne Corporation (NASDAQ:TECH) shareholders might be concerned after seeing the share price drop 17% in the last quarter. On the bright side the share price is up over the last half decade. Unfortunately its return of 46% is below th... Full story
Yahoo Finance • 2 months ago
JT Toppin (41 points) leads No. 12 Texas Tech past ASU in 2 OTs
JT Toppin scored a career-high 41 points and secured a steal with 33 seconds remaining in the second overtime as No. 12 Texas Tech escaped with a wild 111-106 win over Arizona State on Wednesday in Lubbock, Texas.... Full story
Yahoo Finance • 2 months ago
Amid DeepSeek frenzy, Chinese companies detail use of AI
Chinese automaker Great Wall Motor and China's leading telecoms providers are integrating the AI model released by DeepSeek into their offerings, the latest Chinese companies looking to capitalize on the start-up's breakthrough and attenti... Full story
Yahoo Finance • 3 months ago
UCF fends off Texas Tech, wins sixth straight
UCF was steady in the first half against Texas Tech, then dominated early in the second to roll into Lubbock and open Big 12 Conference play with a gritty 87-83 triumph on Tuesday.... Full story
Yahoo Finance • 4 months ago
No. 20 North Carolina holds off Georgia Tech in ACC opener
Seth Trimble scored a team-high 19 points, helping lead No. 20 North Carolina to a 68-65 win over visiting Georgia Tech in the Atlantic Coast Conference opener for both teams in Chapel Hill, N.C. on Saturday.... Full story
Yahoo Finance • 4 months ago
TikTok parent ByteDance’s valuation hits $300 billion amid US ban uncertainty, WSJ reports
TikTok's Chinese parent company ByteDance is valuing itself at about $300 billion after a recent buyback offer, the Wall Street Journal reported on Saturday, even as the tech giant's popular TikTok app faces the prospect of a looming ban i... Full story
Yahoo Finance • 6 months ago
ScaleReady announces a G-Rex® Grant has been awarded to renowned cancer immunologist Dr. Christopher A. Klebanoff
ST. PAUL, Minn., Oct. 7, 2024 /PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that Christopher A. Klebanoff, MD, a physician-scientist at M... Full story
Yahoo Finance • 6 months ago
BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT
MINNEAPOLIS, Sept. 18, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today issued its 2024 Corporate Sustainability Report (CSR), detailing the continued progress advancing its Environmental, Social and Governance (ESG) initia... Full story
Yahoo Finance • 6 months ago
ScaleReady announces a G-Rex® Grant has been awarded to ImmunoScape
ST. PAUL, Minn., Sept. 18, 2024 /PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that ImmunoScape Pte. Ltd. (a Singapore-U.S. based TCR-T th... Full story
Yahoo Finance • 6 months ago
Verismo Therapeutics Awarded a ScaleReady™ G-Rex® Grant
PHILADELPHIA, Sept. 17, 2024 /PRNewswire/ -- Verismo Therapeutics, a clinical-stage CAR T company developing the novel KIR-CAR platform technology, today announced that it has been awarded a $150,000 G-Rex Grant by ScaleReady™. This grant... Full story
Yahoo Finance • 6 months ago
ScaleReady announces a G-Rex® Grant has been awarded to Verismo Therapeutics
ST. PAUL, Minn., Sept. 17, 2024 /PRNewswire/ -- ScaleReadyTM, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReadyTM, today announced that it has awarded a $150,000 G-Rex Grant to Verismo Th... Full story
Yahoo Finance • 6 months ago
ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex® Manufacture of CAR-T and TCR Therapies
ST. PAUL, Minn., Sept. 16, 2024 /PRNewswire/ -- ScaleReady and Bio-Techne Corporation (NASDAQ: TECH) today announced the launch of the G-Rex optimized ProPakTM GMP Cytokines, ideally tailored to high efficiency closed system cell and gene-... Full story
Yahoo Finance • 7 months ago
Some May Be Optimistic About Bio-Techne's (NASDAQ:TECH) Earnings
Soft earnings didn't appear to concern Bio-Techne Corporation's (NASDAQ:TECH) shareholders over the last week. Our analysis suggests that while the profits are soft, the foundations of the business are strong. Check out our latest analysi... Full story
Yahoo Finance • 7 months ago
Bio-Techne Full Year 2024 Earnings: EPS Misses Expectations
Bio-Techne (NASDAQ:TECH) Full Year 2024 Results Key Financial Results Revenue: US$1.16b (up 2.0% from FY 2023). Net income: US$168.1m (down 41% from FY 2023). Profit margin: 14% (down from 25% in FY 2023). The decrease in margin was driv... Full story
Yahoo Finance • 8 months ago
BIO-TECHNE DECLARES DIVIDEND
MINNEAPOLIS, Aug. 7, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30, 2024. The quarterly dividend will be paya... Full story
Yahoo Finance • 8 months ago
BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
MINNEAPOLIS, Aug. 7, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ending June 30, 2024. Fourth Quarter FY2024 Highlights Fourth quarter organic revenue increased b... Full story
Yahoo Finance • last year
SCIENTISTS AT THE WCBP CONFERENCE HIGHLIGHT ADVANCEMENTS IN PROTEIN BIOTHERAPEUTIC CHARGE HETEROGENEITY CHARACTERIZATION USING THE MauriceFlex™ SYSTEM
MINNEAPOLIS, Jan. 24, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) had the honor of welcoming presentations from leading scientists from two major biopharmaceutical companies, Pfizer and Sanofi, at the WCBP conference held in... Full story
Yahoo Finance • last year
BIO-TECHNE ANNOUNCES SUBMISSION OF FDA DRUG MASTER FILE FOR EXCELLERATE GMP IPSC EXPANSION MEDIUM SUPPORTING STEM CELL THERAPY
MINNEAPOLIS, Dec. 20, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA) for its ExCellerate™ GMP iPSC Expansion Medium, An... Full story
Yahoo Finance • last year
LUNAPHORE AND SIB AWARDED INNOSUISSE FUNDING TO DEVELOP INNOVATIVE AI-BASED ASSAY DEVELOPMENT TOOLS
MINNEAPOLIS, Dec. 14, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Lunaphore, a Bio-Techne brand, and SIB Swiss Institute of Bioinformatics, have been awarded Innosuisse funding for an innovation project.... Full story
Yahoo Finance • last year
Should You Hold Bio-Techne Corporation (TECH) For the Long Term?
Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund outperformed the Russell 2000... Full story
